IL89166A0 - Pharmaceutical compositions comprising insulin-like growth factor i - Google Patents

Pharmaceutical compositions comprising insulin-like growth factor i

Info

Publication number
IL89166A0
IL89166A0 IL8989166A IL8916689A IL89166A0 IL 89166 A0 IL89166 A0 IL 89166A0 IL 8989166 A IL8989166 A IL 8989166A IL 8916689 A IL8916689 A IL 8916689A IL 89166 A0 IL89166 A0 IL 89166A0
Authority
IL
Israel
Prior art keywords
insulin
pharmaceutical compositions
growth factor
growth
factor
Prior art date
Application number
IL8989166A
Other languages
English (en)
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Priority to IL10477789A priority Critical patent/IL104777A/en
Publication of IL89166A0 publication Critical patent/IL89166A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL8989166A 1988-02-05 1989-02-03 Pharmaceutical compositions comprising insulin-like growth factor i IL89166A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL10477789A IL104777A (en) 1988-02-05 1989-02-03 Pharmaceutical preparations containing insulin-like growth factor I

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88810072 1988-02-05

Publications (1)

Publication Number Publication Date
IL89166A0 true IL89166A0 (en) 1989-09-10

Family

ID=8200571

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8989166A IL89166A0 (en) 1988-02-05 1989-02-03 Pharmaceutical compositions comprising insulin-like growth factor i

Country Status (13)

Country Link
US (1) US4988675A (de)
EP (1) EP0331630B1 (de)
JP (1) JP2831017B2 (de)
KR (1) KR0131087B1 (de)
AU (1) AU624595B2 (de)
CA (1) CA1336815C (de)
DE (1) DE68905205T2 (de)
DK (1) DK169233B1 (de)
IE (1) IE63163B1 (de)
IL (1) IL89166A0 (de)
NZ (1) NZ227857A (de)
PH (1) PH26085A (de)
ZA (1) ZA89855B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440928B1 (en) 1988-12-06 2002-08-27 Colorado State University Research Foundation Method for treating diabetic neuropathy with NGF
GB8920381D0 (en) * 1989-09-08 1989-10-25 Greater Glasgow Health Board Treatment of insulin-resistant diabetes
US5128320A (en) * 1990-01-18 1992-07-07 Genentech, Inc. Method of restoring normal growth, weight gain or lean body mass in patients with glucocorticoid excess by administering igf-i
US5681814A (en) * 1990-06-07 1997-10-28 Genentech, Inc. Formulated IGF-I Composition
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
SE9100099D0 (sv) * 1991-01-11 1991-01-11 Kabi Pharmacia Ab Use of growth factor
SE9201573D0 (sv) * 1992-05-19 1992-05-19 Kabi Pharmacia Ab Use of igf-1
CA2114419A1 (en) * 1992-06-08 1993-12-23 Peter D. Gluckman Use of growth factor igf-i and/or igf-ii
US20070078089A1 (en) * 1992-07-06 2007-04-05 Ishii Douglas N Method for effecting changes in the central nervous system by administration of IGF-I or IGF-II
ES2095086T3 (es) * 1992-10-29 1997-02-01 Genentech Inc Metodo para el tratamiento y la prevencion de la obesidad.
WO1994016722A1 (en) * 1993-01-25 1994-08-04 The Beth Israel Hospital Association Method for modifying, diagnosing, and screening for igf-i sensitive cell barrier properties
US5446024A (en) * 1993-12-17 1995-08-29 Genentech, Inc. Purification of insulin-like growth factor
SE9402331D0 (sv) * 1994-07-01 1994-07-01 Pharmacia Ab New use
SE9402370D0 (sv) * 1994-07-04 1994-07-04 Pharmacia Ab Use of IGF-I
US5728676A (en) * 1994-09-08 1998-03-17 Ciba-Geigy Corporation Use of insulin-like growth factors I and II for inhibition of inflammatory response
US5565428A (en) * 1995-05-22 1996-10-15 Genentech, Inc. Method of administration of IGF-I
US5741776A (en) * 1995-05-22 1998-04-21 Genentech, Inc. Method of administration of IGF-I
EP0766966A3 (de) * 1995-09-08 2001-02-28 Eli Lilly And Company Methode zur Behandlung der Insulinresistenz
US5783556A (en) * 1996-08-13 1998-07-21 Genentech, Inc. Formulated insulin-containing composition
US6025368A (en) * 1997-02-25 2000-02-15 Celtrix Pharmaceuticals, Inc. Method for treating the symptoms of chronic stress-related disorders using IGF
US6015786A (en) * 1997-02-25 2000-01-18 Celtrix Pharmaceuticals, Inc. Method for increasing sex steroid levels using IGF or IGF/IGFBP-3
US6514937B1 (en) 1997-02-25 2003-02-04 Celtrix Pharmaceuticals, Inc. Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3
US5916569A (en) * 1997-03-26 1999-06-29 E. Martin Spencer Human erectile dysfunction and methods of treatment
US20030069177A1 (en) * 2000-05-16 2003-04-10 Genentech, Inc. Method for treating cartilage disorders
US6420518B1 (en) 1997-04-04 2002-07-16 Genetech, Inc. Insulin-like growth factor agonist molecules
US6121416A (en) 1997-04-04 2000-09-19 Genentech, Inc. Insulin-like growth factor agonist molecules
CA2356109C (en) * 1999-01-06 2008-04-22 Genentech, Inc. Insulin-like growth factor (igf) i mutant variants
CA2369451C (en) * 1999-04-08 2009-09-22 Genentech, Inc. Composition based on oppositely-charged polypeptides
US6040292A (en) * 1999-06-04 2000-03-21 Celtrix Pharmaceuticals, Inc. Methods for treating diabetes
CA2369839A1 (en) * 1999-06-25 2001-01-04 Minimed, Inc. Compositions of insulin and insulin-related peptide for treating diabetes
AU2001288443B2 (en) * 2000-08-29 2007-06-07 Aurogen Inc. Method for treating the central nervous system by administration of IGF structural analogs
CN100439397C (zh) * 2001-02-09 2008-12-03 基因技术股份有限公司 Igf-1的结晶
AU2002248464A1 (en) 2001-02-21 2002-09-12 Medtronic Minimed, Inc. Stabilized insulin formulations
US7071300B2 (en) * 2001-03-14 2006-07-04 Genentech, Inc. IGF antagonist peptides
US6737401B2 (en) 2001-06-28 2004-05-18 Metronic Minimed, Inc. Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
DE10316583A1 (de) * 2003-04-10 2004-10-28 B.R.A.H.M.S Aktiengesellschaft Bestimmung eines midregionalen Proadrenomedullin-Teilpeptids in biologischen Flüssigkeiten zu diagnostischen Zwecken, sowie Immunoassays für die Durchführung einer solchen Bestimmung
WO2005020898A2 (en) * 2003-08-21 2005-03-10 Tercica, Inc. Methods of reducing visceral fat by increasing levels of insulin-like growth factor-i (igf-i)
EP1791551B1 (de) * 2004-08-30 2020-02-26 Ipsen Biopharmaceuticals, Inc. Verfahren und vorrichtung zur diagnose und behandlung von mangelstörung an insulinähnlichem wachstumsfaktor
KR102288366B1 (ko) * 2018-03-09 2021-08-10 경북대학교 산학협력단 한속단 추출물을 유효성분으로 포함하는 비만 예방 또는 치료용 약학적 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3486216T2 (de) * 1983-04-25 1994-02-17 Chiron Corp Hybrid-DNS-Synthesis von reifen insulinähnlichen Wachstumsfaktoren.

Also Published As

Publication number Publication date
KR890012667A (ko) 1989-09-18
IE890357L (en) 1989-08-05
DK52189D0 (da) 1989-02-03
DE68905205T2 (de) 1993-07-22
NZ227857A (en) 1992-04-28
KR0131087B1 (ko) 1998-04-17
ZA89855B (en) 1989-10-25
JPH01233227A (ja) 1989-09-19
AU2899989A (en) 1989-08-10
DE68905205D1 (de) 1993-04-15
AU624595B2 (en) 1992-06-18
JP2831017B2 (ja) 1998-12-02
EP0331630B1 (de) 1993-03-10
IE63163B1 (en) 1995-03-22
CA1336815C (en) 1995-08-29
US4988675A (en) 1991-01-29
DK169233B1 (da) 1994-09-19
PH26085A (en) 1992-02-06
DK52189A (da) 1989-08-06
EP0331630A1 (de) 1989-09-06

Similar Documents

Publication Publication Date Title
GB2222772B (en) Pharmaceutical compositions
GB2219940B (en) Pharmaceutical compositions
EP0403578A4 (en) Stable pharmaceutical composition
AU4447189A (en) Oral compositions
HU896876D0 (en) Pharmaceutical compositions
GB8825892D0 (en) Pharmaceutical composition
ZA893422B (en) Pharmaceutical composition
IL104777A0 (en) Pharmaceutical compositions comprising insulin-like growth factor i
NZ268125A (en) Growth hormone pharmaceutical composition
GB2217202B (en) Trimelamol-containing pharmaceutical compositions
GB8830406D0 (en) Pharmaceutical compositions
GB8809840D0 (en) Pharmaceutical compositions
GB8815444D0 (en) Pharmaceutical compositions
GB8826289D0 (en) Pharmaceutical compositions
GB8830174D0 (en) Pharmaceutical compositions
GB8815443D0 (en) Pharmaceutical compositions
ZA897139B (en) Pharmaceutical compositions
GB8808117D0 (en) Pharmaceutical compositions
GB8808830D0 (en) Pharmaceutical compositions
GB8809650D0 (en) Pharmaceutical compositions
GB8820265D0 (en) Pharmaceutical compositions
ZA893224B (en) Pharmaceutical compositions
GB8830169D0 (en) Pharmaceutical compositions
GB8809225D0 (en) Pharmaceutical compositions
GB8829368D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)
KB Patent renewed
KB Patent renewed
KB Patent renewed